Abstract
The present project initially aimed in Phase 1 to evaluate the technical and scientific feasibility of a product with incremental innovation intended for bone regeneration, specifically a bone graft with sustained release of bioactive compounds. These bioactives present synergistic action when combined in composite form, demonstrating angiogenic, proliferative, and antimicrobial activitie…